Patents by Inventor Kristine M. Kim

Kristine M. Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for preparing monoclonal antibodies recognizing glycan binding site as an epitope
    Patent number: 10150961
    Abstract: The present disclosure relates to a method for producing a monoclonal antibody that binds to an epitope for the glycan binding site of a glycoprotein. According to the present disclosure, a monoclonal antibody that recognizes the glycan binding site of a glycoprotein as an epitope can be produced in a relatively simple and economic manner, and a monoclonal antibody having high sensitivity and specificity for the glycan binding site of a glycoprotein can be produced. The monoclonal antibody produced according to the present disclosure can be effectively used as an agent for diagnosing or treating various diseases associated with a change in glycan structure or glycan expression level.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: December 11, 2018
    Assignees: Seoul National University R&DB Foundation, Kangwon National University Industry Cooperation Foundation
    Inventors: Eugene C. Yi, Min Jueng Kang, Kristine M. Kim, Eunhee G. Kim
  • METHODS FOR PREPARING MONOCLONAL ANTIBODIES RECOGNIZING GLYCAN BINDING SITE AS AN EPITOPE
    Publication number: 20140162890
    Abstract: The present disclosure relates to a method for producing a monoclonal antibody that binds to an epitope for the glycan binding site of a glycoprotein. According to the present disclosure, a monoclonal antibody that recognizes the glycan binding site of a glycoprotein as an epitope can be produced in a relatively simple and economic manner, and a monoclonal antibody having high sensitivity and specificity for the glycan binding site of a glycoprotein can be produced. The monoclonal antibody produced according to the present disclosure can be effectively used as an agent for diagnosing or treating various diseases associated with a change in glycan structure or glycan expression level.
    Type: Application
    Filed: July 19, 2013
    Publication date: June 12, 2014
    Inventors: Eugene C. Yi, Min Jueng Kang, Kristine M. Kim, Eunhee G. Kim
  • Tweak receptor
    Patent number: 8414895
    Abstract: The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: April 9, 2013
    Assignee: Immunex Corporation
    Inventors: Kristine M. Kim, Steven R. Wiley, Randal R. Ketchem, William C. Fanslow, III
  • TWEAK RECEPTOR
    Publication number: 20110020267
    Abstract: The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.
    Type: Application
    Filed: October 6, 2010
    Publication date: January 27, 2011
    Inventors: Kristine M. Kim, Steven R. Wiley, Randal R. Ketchem, William C. Fanslow, III
  • TWEAK receptor
    Patent number: 7829675
    Abstract: The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: November 9, 2010
    Assignee: Immunex Corporation
    Inventors: Kristine M. Kim, Steven R. Wiley, Randal R. Ketchem, William C. Fanslow, III
  • TWEAK RECEPTOR
    Publication number: 20090137036
    Abstract: The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.
    Type: Application
    Filed: January 16, 2009
    Publication date: May 28, 2009
    Inventors: KRISTINE M. KIM, Steven R. Wiley, Randal R. Ketchem, William C. Fanslow, III
  • TWEAK receptor
    Patent number: 7495086
    Abstract: The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: February 24, 2009
    Assignee: Immunex Corporation
    Inventors: Kristine M. Kim, Steven R. Wiley, Randal R. Ketchem, William C. Fanslow, III